COLLABORATIVE GENOMIC STUDY OF BIPOLAR DISORDER
双相情感障碍的合作基因组研究
基本信息
- 批准号:6392435
- 负责人:
- 金额:$ 9.06万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1998
- 资助国家:美国
- 起止时间:1998-09-30 至 2002-08-31
- 项目状态:已结题
- 来源:
- 关键词:behavioral genetics bipolar depression cell line clinical research computer assisted sequence analysis computer data analysis computer program /software cryopreservation diagnosis quality /standard family genetics genetic markers genetic registry /resource /referral center genetic susceptibility genome genotype human data human genetic material tag human subject information systems interview linkage mapping mental disorder diagnosis phenotype
项目摘要
DESCRIPTION: (Adapted from investigator's abstract) Bipolar affective
disorder is a severe heritable condition affecting about one person of the
population. The mode of inheritance is poorly understood and probably
involves multiple loci of small to moderate effect. Genic linkage studies
have not been robust although some reports of linkage have been replicated
several times. The NIMH began a national archival database for search of
linked genes in this condition in 1988. Its purpose ws to collect a large
sample of interviews and cell lines from families suitable for linkage and
association studied. Four centers participated in the initiative: Indian
University, Johns Hopkins University, Washington University of St. Louis,
and the NIMH Intramural Program. A new structured polydiagnostic
interview, the Diagnostic Interview for Genetic Studies (DIGS), was
developed and field-tested. Ascertainment was begun in 1999 to identify
Bipolar I (BPI) probands with a BPI or Schizoaffective Bipolar type
(SA/BP) first degree relative. Two hundred and forty-three families have
been enrolled in the program including 1025 affected subjects. Twenty one
hundred sixty five structured interviews have been given and 2097
immortalized cell lines have been cryopreserved. A genomic survey has been
completed on 540 subjects selected from 97 families and eight candidate
areas for linkage have been identified, some supporting previous findings.
These cell lines and related clinical information has bene publicly
released. A follow-up sample is presently being genotyped, with particular
attention to areas of interest identified in the original survey.
It is proposed to extend the present study through families identify by
a BPI-BPI sib pair at eight sites (Indiana, Washington University of St.
Louis, Johns Hopkins, University of Pennsylvania, University of
California, San Diego, University of Utah, University of Chicago, and
University of Iowa). A total of 450 new families and 2500 cell lines and
interviews over the next four years will be added. This sample will be
used to confirm and extend present findings of linkage, to narrow the
implicated regions, and to test candidate genes. Genotypes will be shared
with a consortium of investigators studying linkage in bipolar illness.
Cell lines and interview data will be made freely available to the
scientific community.
描述:(改编自研究者摘要)双相情感
疾病是一种严重的遗传性疾病,
人口遗传方式知之甚少,
涉及多个小到中等影响的位点。基因连锁研究
尽管有一些关于联系的报告被重复,
多次NIMH开始建立一个国家档案数据库,
1988年,在这种情况下,它的目的是收集大量的
样本的采访和细胞系从家庭适合的联系,
协会研究。四个中心参加了该倡议:印度
大学、约翰霍普金斯大学、华盛顿圣路易斯大学、
以及NIMH校内项目。一种新的结构化多诊断
遗传研究诊断访谈(Diagnosis Interview for Genetic Studies,DIGS)
开发和实地测试。1999年开始查明
双相I型(BPI)先证者为BPI或分裂情感型双相型
(SA/BP)一级亲属。243个家庭
该计划共招募了1025名受影响受试者。Twenty one
已经进行了165次结构化访谈,
将永生化细胞系冷冻保存。一项基因组调查
完成了从97个家庭和8名候选人中选出的540名受试者
已经确定了联系的领域,其中一些支持以前的调查结果。
这些细胞系和相关的临床信息贝内,
发布目前正在对后续样本进行基因分型,特别是
注意在最初调查中确定的关注领域。
建议将目前的研究扩展到以下家庭:
在八个地点(印第安纳州、华盛顿大学圣路易斯分校),
路易斯,约翰霍普金斯,宾夕法尼亚大学,
加州、圣地亚哥、犹他州大学、芝加哥大学,以及
爱荷华州大学)。总共有450个新的家族和2500个细胞系,
将增加未来四年的采访。该样品将
用于确认和扩展目前的联系发现,缩小
涉及的区域,并测试候选基因。基因型将共享
与一个研究双相情感障碍的研究者联盟合作。
细胞系和访谈数据将免费提供给
科学界。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM A SCHEFTNER其他文献
WILLIAM A SCHEFTNER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM A SCHEFTNER', 18)}}的其他基金
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6861023 - 财政年份:1998
- 资助金额:
$ 9.06万 - 项目类别:
A Collaborative Genomic Study of Bipolar Disorder
双相情感障碍的合作基因组研究
- 批准号:
6991250 - 财政年份:1998
- 资助金额:
$ 9.06万 - 项目类别:
相似海外基金
Psilocybin Assisted Psychotherapy for Bipolar Depression: An fMRI Emotional-Processing Pilot Study
裸盖菇素辅助双相抑郁心理治疗:功能磁共振成像情绪处理试点研究
- 批准号:
486939 - 财政年份:2023
- 资助金额:
$ 9.06万 - 项目类别:
Miscellaneous Programs
Repeated Ketamine Infusions for Cognitive Impairment in Treatment-Resistant Bipolar Depression
反复输注氯胺酮治疗难治性双相抑郁症的认知障碍
- 批准号:
486443 - 财政年份:2022
- 资助金额:
$ 9.06万 - 项目类别:
Studentship Programs
Reward and stress: Developing neuroimaging biomarkers for bipolar depression
奖励和压力:开发双相抑郁症的神经影像生物标志物
- 批准号:
2748645 - 财政年份:2022
- 资助金额:
$ 9.06万 - 项目类别:
Studentship
Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression: An Emotional-Processing fMRI Pilot Study
裸盖菇素对治疗难治性双相抑郁症的神经生物学作用:情绪处理功能磁共振成像初步研究
- 批准号:
486577 - 财政年份:2022
- 资助金额:
$ 9.06万 - 项目类别:
Studentship Programs
Theta-burst stimulation for bipolar depression: A randomized controlled trial
θ 爆发刺激治疗双相抑郁症:一项随机对照试验
- 批准号:
469571 - 财政年份:2022
- 资助金额:
$ 9.06万 - 项目类别:
Operating Grants
Cannabidiol Adjunctive Therapy for Acute Bipolar Depression: A Randomized Double-Blind Placebo Controlled Trial
大麻二酚辅助治疗急性双相抑郁症:随机双盲安慰剂对照试验
- 批准号:
444068 - 财政年份:2021
- 资助金额:
$ 9.06万 - 项目类别:
Operating Grants
Repeated Ketamine Infusions for Treatment-Resistant Bipolar Depression: A Randomized, Midazolam-Controlled Phase II Clinical Trial
重复氯胺酮输注治疗难治性双相抑郁症:一项随机、咪达唑仑对照的 II 期临床试验
- 批准号:
434675 - 财政年份:2020
- 资助金额:
$ 9.06万 - 项目类别:
Operating Grants
Next Generation Drugs for Bipolar Depression and Maintenance
治疗双相抑郁症和维持治疗的下一代药物
- 批准号:
9555300 - 财政年份:2018
- 资助金额:
$ 9.06万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10080262 - 财政年份:2018
- 资助金额:
$ 9.06万 - 项目类别:
Next generation drugs for bipolar depression and maintenance
用于双相抑郁症和维持治疗的下一代药物
- 批准号:
10588254 - 财政年份:2018
- 资助金额:
$ 9.06万 - 项目类别: